Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Co-infection among HIV infected individuals at tertiary care hospital in western Nepal

被引:8
作者
Supram, Hosuru Subramanya [1 ]
Gokhale, Shishir [1 ]
Sathian, Brijesh [2 ]
Bhatta, Dharma Raj [1 ]
机构
[1] Manipal Coll Med Sci, Dept Microbiol, Pokhara, Nepal
[2] Manipal Coll Med Sci, Dept Community Med, Pokhara, Nepal
来源
NEPAL JOURNAL OF EPIDEMIOLOGY | 2015年 / 5卷 / 02期
关键词
HIV; HBV; HCV; Co-infection;
D O I
10.3126/nje.v5i2.12831
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: The HIV, HBV and HCV viruses are the major public health concern all over the world including Nepal. The aim of the study is to determine the rate of HBV and HCV co-infections in patients with HIV infection. Methods: The study cohort included 218 consecutive HIV infected patients who were examined for co-infection with HBV or HCV or both at Manipal teaching hospital, Western Nepal. The demographic data of the subjects was collected retrospectively. The data was analyzed with SPSS software and EPI Info to measure the correlation of variables and infection rates. Results: In the course of six years study period, a total of 25,708 samples were collected for HIV screening test. The 218 (0.8%) screen test positive for HIV were confirmed as per WHO guidelines. The overall rate of co-infection with HBV and or HCV was 7.3% (16 of 218 patients). Only 7 (3.2% [CI 1.3, 6.5]) were positive for both HIV and HBV infection markers and 9 (4.1% [CI 1.9, 7.7]) were positive for HIV and HCV infection markers. None were positive of all three virus markers. Conclusion: It is advisable to implement regular screening for Hepatitis B Virus and Hepatitis C Virus among all HIV infected individuals and their sexual partners.
引用
收藏
页码:488 / 493
页数:6
相关论文
共 18 条
  • [1] Ahuja S, 2013, JIMSA, V26, P91
  • [2] Prevalence and risk factors of hepatitis B and C virus infections among the general population and blood donors in Morocco
    Baha, Warda
    Foullous, Abderrahim
    Dersi, Noureddine
    They-they, Thierry Paluku
    El Alaoui, Khadija
    Nourichafi, Nadia
    Oukkache, Bouchra
    Lazar, Fatiha
    Benjelloun, Soumaya
    Ennaji, My Mustapha
    Elmalki, Abdelouhad
    Mifdal, Hassan
    Bennani, Abdelouaheb
    [J]. BMC PUBLIC HEALTH, 2013, 13
  • [3] Ben Halima S, 2010, N AFRICA VIROL J, V15, P7
  • [4] Chuang WL, 2005, ANTIVIR THER, V10, P125
  • [5] Ghimire P, 2008, J NEPAL HLTH RES COU, V4, P26
  • [6] Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only
    Hofer, M
    Joller-Jemelka, HI
    Grob, PJ
    Luthy, R
    Opravil, M
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1998, 17 (01) : 6 - 13
  • [7] Hepatic safety and tolerability of raltegravir among HIV patients coinfected with hepatitis B and/or C
    Hurt, Christopher B.
    Napravnik, Sonia
    Moore, Richard D.
    Eron, Joseph J., Jr.
    [J]. ANTIVIRAL THERAPY, 2014, 19 (04) : 415 - 422
  • [8] Karki S, 2009, SE ASIAN J TROP MED, V40, P66
  • [9] Co-infection with hepatitis viruses among HIV-infected individuals at a tertiary care centre in South India
    Kosaraju, Kranthi
    Padukone, Shashiraja
    Bairy, Indira
    [J]. TROPICAL DOCTOR, 2011, 41 (03) : 170 - 171
  • [10] HIV-HBV Coinfection - A Global Challenge
    Kourtis, Athena P.
    Bulterys, Marc
    Hu, Dale J.
    Jamieson, Denise J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (19) : 1749 - 1752